A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Name: A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
License: Public Domain

Linnaeus Therapeutics, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

melanoma (skin cancer), melanoma stage iiib-iv, cutaneous melanoma, unresectable melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 268033
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.